| Literature DB >> 22715333 |
Julian P Saboisky1, Jane E Butler, Simon C Gandevia, Danny J Eckert.
Abstract
The causes of obstructive sleep apnea (OSA) are multifactorial. Neural injury affecting the upper airway muscles due to repetitive exposure to intermittent hypoxia and/or mechanical strain resulting from snoring and recurrent upper airway closure have been proposed to contribute to OSA disease progression. Multiple studies have demonstrated altered sensory and motor function in patients with OSA using a variety of neurophysiological and histological approaches. However, the extent to which the alterations contribute to impairments in upper airway muscle function, and thus OSA disease progression, remains uncertain. This brief review, primarily focused on data in humans, summarizes: (1) the evidence for upper airway sensorimotor injury in OSA and (2) current understanding of how these changes affect upper airway function and their potential to change OSA progression. Some unresolved questions including possible treatment targets are noted.Entities:
Keywords: myopathy; neuropathy; sleep apnea; upper airway muscles; upper airway physiology; upper airway reflexes
Year: 2012 PMID: 22715333 PMCID: PMC3375463 DOI: 10.3389/fneur.2012.00095
Source DB: PubMed Journal: Front Neurol ISSN: 1664-2295 Impact factor: 4.003
Figure 1Types of evidence for neuromuscular pathology in OSA. MUSCLE: Remodelling may be reflected via anatomical changes within the upper airway muscles (red); EFFERENT: changes in the electromyogram (EMG) of the upper airway muscles innervated via the cranial nerves (blue); AFFERENT: changes in sensory pathways (green). NCAM=neural cell adhesion molecule.
Percentage of Type I, Type IIA, and Type IIB muscle fibers in non-OSA and patients with OSA.
| Muscle | Non-OSA % of fibers | OSA % of fibers | Author | ||||
|---|---|---|---|---|---|---|---|
| Type I | Type IIA | Type IIB | Type I | Type IIA | Type IIB | ||
| Genioglossus | 61 | 39 | 41 | 59 | Carrera et al. ( | ||
| 33.3 | 48.8 | 18.3 | 33 | 53.3 | 11.6 | Series et al. ( | |
| Palatopharyngeus | 13.7 | 31.5 | 1.6 | 22.1 | 58.4 | 0.5 | Lindman and Stal ( |
| 26 | 77 | 16 | 87 | De Vuono et al. ( | |||
| Medium pharyngeal constrictor | 49 | 41.3 | 9.7 | 22.4 | 75.2 | 2.4 | Smirne et al. ( |
| 51.9 | 36.1 | 11.8 | 30.7 | 61.8 | 7.5 | Ferini-Strambi et al. ( | |
| Uvula | 15.2 | 69.2 | 10.1 | 10.7 | 82.6 | 4.3 | Series et al. ( |
| 10.6 | 73.5 | 15.9 | 8.1 | 82.3 | 9.6 | Series et al. ( | |
| ∼15 | 76.1 | – | ∼1.8 | 89.4 | – | Series et al. ( | |
| 12.8 | 65.3 | 4.8 | 19.5 | 55.8 | 16.1 | Lindman and Stal ( | |
Histological biopsy studies have confirmed differences in the muscle properties between non-OSA subjects and patients with OSA. There is an increase in the fraction of Type IIA fiber types in human upper airway musculature. Note: Type IIB fibers in humans are now referred to as Type IIX. Note: some rows do not total 100%. In some cases the number of Type IIB fibers were too low to be considered for calculation (e.g., Series et al., .
Anatomical structural changes.
| Reference | Main findings | Comments |
|---|---|---|
| Woodson et al. ( | Soft palate and uvula biopsy; histological differences in soft palate and uvula in OSA vs. snorers and non-snorers measured via electron microscopy | Notes A and B |
| • Focal degeneration of myelinated nerve fibers and axons in OSA | ||
| • Focal muscle fiber atrophy in snorers and OSA | ||
| • Muscle bundle disruption and fiber degeneration in all snorers and OSA | ||
| Edstrom et al. ( | Palatopharyngeal muscle biopsy; neurogenic changes in OSA vs. non-OSA | Note A |
| • ↑ Number of angulated atrophic fibers | ||
| • Fiber type grouping | ||
| • Muscle fiber atrophy | ||
| Series et al. ( | Uvula biopsy; altered anatomy and function in OSA patients vs. snorers | All subjects had sleep studies |
| • ↑ Cross-sectional area and Type IIA muscle fiber area in OSA | No healthy control group | |
| • Creative kinase, GADPH, phosphofructokinase, and phosphorylase ↑ in OSA (all elements in the anaerobic pathway) | Findings consistent with a muscle training effect | |
| • ↑ Twitch and tetanic tension in OSA | ||
| • Fatigability index similar between the two groups | ||
| Series et al. ( | Uvula and genioglossus biopsies; altered anatomy in OSA patients vs. snorers | All subjects had sleep studies |
| • Uvula ↑ glycolytic, glycogenolytic, and anaerobic enzyme activities | No healthy control group | |
| • No difference in genioglossus glycolytic and anaerobic enzyme activities | Snorers had a low AHI | |
| • Uvula and genioglossus: ↑ Type IIA, ↓ Type IIB muscle fiber%, and no change in muscle fiber area | Findings consistent with a muscle training effect | |
| Friberg et al. ( | Soft palate mucosa biopsy; neurogenic changes in OSA | Note A |
| • ↑ Density of afferent nerve endings in epithelium | Non-OSA = chronic tonsillitis and one pharyngeal tumor | |
| • ↑ Number of varicose nerve endings in epithelium | ||
| • ↑ Nerves containing neuropeptides (↑ PGP9.5 density indicating increased neurons and nerve fibers) | Epithelium thicker in OSA | |
| Ferini-Strambi et al. ( | Medium pharyngeal constrictor and quadricep biopsies; altered anatomy of pharyngeal constrictor, but, not quadricep muscle in OSA | OSA based on clinical symptoms and portable monitor |
| • ↑ % Type I, ↑ % Type IIA, and ↓ % Type IIB | ||
| • ↑ Type IIA fiber diameter | ||
| Friberg et al. ( | Palatopharyngeal and anterior tibial biopsies; altered anatomy of palatopharyngeal, but, not in anterior tibial muscle in OSA vs. non-OSA | Note A, interviewed history, and spouses |
| • Similar palatopharyngeal muscle fiber type distribution | Non-OSA = tonsillectomy chronic tonsillitis, 2 for tumor | |
| • ↑ Palatopharyngeal muscle fiber size variations | ||
| • Rounded atrophic palatopharyngeal muscle fibers | ||
| • ↑ Incidence of centrally located nuclei and split palatopharyngeal muscle fibers | ||
| • Palatopharyngeal muscle fiber type grouping | ||
| Carrera et al. ( | Genioglossus biopsy; altered anatomy and function in OSA vs. non-OSA | Note A |
| • Untreated OSA patients ↑ % Type II muscle fibers, and ↑ fatigability | No break down of muscle fibers into Type IIA and B | |
| • No differences in muscle fiber distribution and fatigability in a separate analysis of CPAP treated patients vs. non-OSA | Not the same subjects pre- and post-treatment | |
| Series et al. ( | Uvula muscle biopsy; altered anatomy in OSA patients vs. snorers | All subjects had sleep studies |
| • ↑ % Type IIA muscle fibers | No control group | |
| • No difference in muscle fiber area in Type I or II, thus, no evidence for atrophy or hypertrophy | ||
| Paulsen et al. ( | Uvula mucosa biopsy; altered anatomy in OSA patients vs. snorers and non-OSA. Measured via electron microscopy | Note B |
| • Absence of connective tissue papillae | ||
| • ↓ Cytokeratins | ||
| • Acanthosis of epithelium | ||
| • ↑ Leukocytes inside the lamina propria | ||
| Lindman and Stal ( | Uvula and palatopharyngeus biopsies; altered anatomy in OSA patients vs. non-OSA | Note B |
| • ↓ Ratio of area of palatopharyngeus muscle fibers to connective tissue in OSA patients | ||
| • ↑ Palatopharyngeus muscle Type I, ↑ Type IIA, and ↓ Type IIAB and IIB muscle fibers in OSA patients | ||
| • ↓ Uvula muscle fiber diameters for all fiber types except Type IIC/IM | ||
| Boyd et al. ( | Soft palate and/or tonsillar pillar biopsies; denervation in OSA patients vs. non-OSA | Note A, screened via questionnaire |
| • ↑ PGP9.5 specifically expressed in the neurons and nerve fibers | ||
| • ↑ Sarcolemmal expression of N-CAM 16 vs. 1% | ||
| De Vuono et al. ( | Palatopharyngeal biopsy; similar findings in children with OSA, vs. snorers vs. controls with the presence of each of the following in similar proportions | All subjects had sleep studies Findings suggest that these histological features may reflect a “normal” muscle rather than neurogenic or myopathic pathology |
| • Muscle fiber size variability | ||
| • Rounded atrophic muscle fibers | ||
| • ↑ Type II muscle fibers | ||
| • Irregular muscle fiber architecture “moth-eaten” | ||
| Stål et al. ( | Uvula and palatopharyngeaus biopsies; altered anatomy in OSA patients vs. non-OSA | Note A, no history of any significant disease Note B |
| • ↓ Capillary density per muscle fiber area | ||
| • Histopathological in all OSA muscle biopsies: fibrosis, variability in fiber size, developmental MyHC isoforms | ||
| Bassiouny et al. ( | Uvula biopsies; degenerative anatomical changes to both myelinated and unmyelinated nerve endings in OSA patients vs. snorers and non-OSA | Note A, confirmed via partners and medical history |
| • Myelin sheath had obvious signs of: degenerated and irregular Schwann cells, lamellated bodies, neurofilament loss, and fatty degeneration | Note B | |
| Non-OSA died from causes unrelated to head and neck | ||
| Stål and Johansson ( | Uvula and palatopharyngeaus biopsies; altered anatomy in OSA patients vs. non-OSA | Note A, previously physically healthy Note B |
| • ↓ Capillaries around abnormal muscle fibers | ||
| • Abnormal mitochondrial distribution | ||
| • Uvula ↑ fiber hypertrophy | ||
| • Palatopharyngeus muscle fibers display signs of both atrophy and hypertrophy in OSA vs. controls |
Note A: indicates that overnight sleep studies were not performed in the non-OSA group.
Note B: indicates that samples from the non-OSA group were obtained via autopsy.
Efferent changes.
| Reference | Main findings | Comments |
|---|---|---|
| Mezzanotte et al. ( | Fine-wire intramuscular multiunit genioglossus electromyography; increased neural drive in OSA vs. non-OSA | Note A |
| • ↑ Peak EMG during quiet breathing | ||
| Fogel et al. ( | Fine-wire intramuscular genioglossus electromyography; increased neural drive in OSA vs. non-OSA | Note A |
| • ↑ EMG during wakefulness (↑ tonic activation and ↑ negative-epiglottic pressure during entrained iron-lung ventilation in inspiration) | Primary analysis included older OSA patients | |
| • No difference in mean EMG/Pepi relationship in OSA and controls under all conditions (basal breathing, iron-lung ventilation and heliox breathing) | Not matched for BMI | |
| • Age matched sub-analysis EMG not increased (but trended ↑ in OSA tonic, peak, and phasic) | ||
| Svanborg ( | Concentric needle single motor unit palatopharyngeus electromyography; neurogenic changes in OSA patients | Note A |
| • 10/12 OSA evidence of lesions: polyphasic potentials, 3/15 snorers exhibited “moderate” lesions | ||
| Saboisky et al. ( | Monopolar needle single motor unit genioglossus electromyography; neurogenic changes in OSA patients vs. controls | Note B Not matched for BMI |
| • ↑ Area and longer duration action potentials | ||
| • Distribution of six unit types identical between groups | ||
| • Inspiratory units recruited earlier in OSA patients | ||
| • ↑ Peak discharge frequencies of Inspiratory Phasic units but, inspiratory tonic ↓ in OSA | ||
| Series et al. ( | Transcrainal magnetic stimulation and surface genioglossus and diaphragm electromyography; different responses in OSA patients vs. controls | Note B |
| • ↓ Latency of genioglossus MEPs during tongue protraction | ||
| • Negative correlation between genioglossus MEP latency and AHI | ||
| • Similar baseline genioglossus EMG activity in OSA patients and controls during quiet breathing | ||
| Ramchandren et al. ( | Hypoglossal nerve conduction; abnormalities in patients with OSA vs. controls | Note A |
| • ↓ Compound muscle action potential amplitudes | Treated OSA subjects | |
| Saboisky et al. ( | Concentric needle MACRO and single motor unit genioglossus electromyography; neurogenic changes in OSA patients vs. controls | Note B Large sample: no timing data minimal frequency data No snoring data BMI matched subjects |
| • ↑ Duration, size index, relative irregularity coefficient, phases, turns, area to amplitude ratio area/phase, and MACRO duration amplitude and area | ||
| • No difference in peak to peak amplitudes | ||
| • Irregularity coefficient correlated with minimal overnight oxygen saturation |
Note A: indicates that overnight sleep studies were not performed in the non-OSA group.
Note B: indicates that both the OSA and non-OSA group had overnight sleep studies.
Afferent changes.
| Reference | Main findings | Comments |
|---|---|---|
| McNicholas et al. ( | Inspiratory resistive load detection thresholds; decreased ability to detect inspiratory resistive loads in OSA patients vs. non-OSA | Note C |
| Clerk et al. ( | Inspiratory resistive loads detection thresholds; not different in normal weight OSA patients | Note C |
| Friberg et al. ( | Soft palate mucosa Laser Doppler perfusion/electrical stimulation; altered afferent nerve regulation in OSA Patients | Note A |
| • ↓ Vasodilatation of the peripheral mucosa of severe OSA patients vs. non-OSA | ||
| Tun et al. ( | Inspiratory resistive load magnitude perception; reduced in untreated OSA vs. non-OSA | Notes A and C |
| • Reversed after 2 weeks CPAP therapy | ||
| Kimoff et al. ( | Two-point discrimination and vibration sensation in the oropharynx, lip, and hand; reduced oropharynx, but, not lip and hand sensation in OSA and non-apneic snorers vs. controls | Note B and C Not matched for BMI |
| • Partial reversibility of changes post-CPAP in OSA, but, still impaired | ||
| • Anesthesia abolished two point discrimination in all patients and ↓ vibratory sensation | ||
| • Similar impairment in both snorers and OSA | ||
| Guilleminault et al. ( | Two-point palatal discrimination; reduced in OSA vs. UARS and controls | Notes B and C |
| Gora et al. ( | Respiratory-related evoked potentials (RREP); no difference in P1 amplitude or latency in OSA vs. non-OSA | Note A |
| Akay et al. ( | Respiratory-related evoked potentials; reductions in early RREP activity in OSA vs. non-OSA | Note A |
| Predominantly CPAP treated OSA patients | ||
| Afifi et al. ( | Respiratory and auditory evoked potentials; no difference in early waveform components in OSA vs. non-OSA | Note B, RDI defined using portable monitor |
| Nguyen et al. ( | Sensory detection thresholds for air-pressure pulses delivered to the oropharynx, velopharynx, hypopharynx, and larynx determined via endoscope; specific alternations in certain OSA patients vs. controls | Notes B and C Reproducible measures after 3 months |
| • Two subgroups of patients with and without abnormal sensory measures at multiple upper airway sites | ||
| • Correlations between laryngeal sensory measures and apnea severity and nadir SaO2 | ||
| Dematteis et al. ( | Sensory perception thresholds at the soft palate to varying airflow rates; reduced sensitivity in OSA patients vs. controls | Notes B and C OSA patients untreated |
| • Pharyngeal sensitivity correlated with OSA severity | ||
| Hlavac et al. ( | Inspiratory resistive load magnitude perception; reduced in untreated OSA vs. controls | Notes B and C |
| Donzel-Raynaud et al. ( | Respiratory-related evoked potentials; no difference in P1 amplitude or latency in OSA vs. controls | Note B |
| Eckert et al., | Respiratory-related evoked potentials and genioglossus and tensor palatini electromyography; no difference in early P1 component and reflex onset latency to brief negative upper airway pressure pulses in untreated OSA patients vs. controls | Note B |
| Sunnergren et al. ( | Soft palate and lip temperature detection thresholds; impaired in OSA patients vs. controls | Notes B and C |
| • Soft palate thresholds: 6.6°C OSA, 5.1°C Snorers, 2.8°C non-snorers | ||
| Grippo et al. ( | Respiratory-related evoked potentials; reductions in early RREP activity in OSA vs. controls | Note B |
| OSA patients untreated |
Note A: indicates that overnight sleep studies were not performed in the non-OSA group.
Note B: indicates that both the OSA and non-OSA group had overnight sleep studies.
Note C: indicates that finding may not represent primary sensory impairment; potentially influenced by confounders such as impairments in cognitive processing or edema related to OSA.
Functional changes.
| Reference | Main findings | Comments | |
|---|---|---|---|
| Mortimore and Douglas ( | Fine-wire intramuscular multiunit levator palatini and palatoglossus electromyography; reduced EMG responses to negative upper airway pressure pulses in OSA patients vs. non-OSA | Note A Large MTA (100 ms) not appropriate for examining reflexes | |
| • CPAP treated patients had similar EMG responses vs. non-OSA | |||
| EMG latencies unknown | |||
| Zohar et al. ( | Swallowing provocation test and scintigraphy testing; altered swallowing reflex in OSA | Minimal sleep monitoring (sound and O2) in non-OSA | |
| • Impaired bolus clearance in the oral cavity | |||
| • Surgery (UPPP) improved bolus clearance but was not related to reductions in RDI | |||
| Teramoto et al. ( | Swallowing provocation test; altered swallowing reflex in OSA vs. age, gender, and BMI matched controls | Note B | |
| • ↓ Onset latency | |||
| • ↓ Inspiratory suppression time from the termination of swallowing to the next onset of inspiration | |||
| • ↑ Provocant required to elicit swallow reflex | |||
| Jäghagen et al. ( | Swallowing provocation and videoradiographic testing; altered swallowing function in OSA patients and snorers vs. non-OSA | Note A | |
| • Impaired swallowing function in 54 vs. 7% in the controls | |||
| • No correlation between swallowing function and severity of snoring | |||
| Levring Jaghagen et al. ( | Swallowing provocation and videoradiographic testing; altered swallowing function in OSA patients and snorers vs. controls | Note A | |
| • Dysfunction in 50% with AHI of >30, 61% AHI of 5–29, and 43% with AHI of <5 events/h | |||
| Berry et al. ( | Multiunit surface and intramuscular genioglossus electromyography; slightly increased amplitude of EMG response to brief negative pressure pulses of moderate but not large magnitude | Note A | |
| MTA not appropriate for examining reflexes | |||
| Eckert et al. ( | Fine-wire intramuscular multiunit genioglossus and tensor palatini electromyography; similar EMG responses in OSA patients vs. controls | Note B Not matched for BMI | |
| • No difference in short latency reflex timing or amplitude to negative pressure pulses | |||
| • Peak genioglossus EMG and epiglottic pressure not different during passive iron-lung ventilation | |||
| Valbuza et al. ( | Swallowing provocation and nasal fibroscopy; Swallowing dysfunction in OSA vs. controls | Note B | |
| • 64% had premature oral leakage to a food/liquid bolus | |||
| Valbuza et al. ( | Palatal and gag reflexes; absence of reflexes in moderate and severe OSA patients | Note B | |
| Mezzanotte et al. ( | Maximal tongue protrusion force; not different in four very severe OSA patients vs. four non-OSA (30 vs. 38 | Note A | |
| Mortimore et al. ( | Tongue protrusion tasks; similar in OSA vs. non-OSA | Note A | |
| • No difference in maximal protrusion strength | Max tongue force only explained ∼4% of the variance in AHI | ||
| • No difference in tongue fatigability measured as time to hold a 50% of maximal contraction | |||
| • No change over the course of a night (AM vs. PM) in strength or fatigability | |||
| • ↓ Tongue strength with ↑ age, ↑ BMI, ↑AHI, and ↑neck size | |||
| Busha et al. ( | Tongue protrusion tasks; similar in OSA vs. non-OSA | Note A | |
| • Optimum length of the genioglossus longer in OSA patients vs. non-OSA | |||
| • At longer muscle lengths ↑ maximal protrusion force in OSA patients | |||
| • Endurance times similar between the two groups | |||
| Blumen et al. ( | Tongue protrusion tasks; recovery longer in OSA vs. controls | Note B | |
| • No change in endurance time or fatigability in OSA patients | |||
| • ↑ Time to recovery of initial maximal force in the OSA patients | |||
| • Final EMG median frequency was significantly higher and the final low-frequency EMG component smaller in the OSA patients | |||
| • Mean endurance time in the OSA patients 75% shorter | |||
| Shepherd et al. ( | Maximal tongue protrusion force; increased in severe OSA (AHI 49 h) | Note B | |
| • Tongue strength not related to AHI | |||
| Eckert et al. ( | Tongue protrusion tasks; altered voluntary tongue protrusion force and fatigability in OSA patients vs. controls | Note B | |
| • ↑ Maximal protrusion force | |||
| • ↓ Time to task failure (70% maximal force 5 s on 5 s off) | |||
Note A: indicates that overnight sleep studies were not performed in the non-OSA group.
Note B: indicates that both the OSA and non-OSA group had overnight sleep studies.